Candidemia in COVID-19 treated with corticosteroids and tocilizumab.

Koichiro YamamotoKaoru NakamuraHideharu Hagiya Fumio Otuska

Published in: Clinical case reports (2021)

COVID-19 patients treated with anti-inflammatory drugs are rarely complicated by candidemia. Since immunosuppressive therapy can blunt inflammatory reactions, clinicians should actively survey latent candidemia during severe COVID-19 treatment.

Keyphrases

coronavirus disease
sars cov
anti inflammatory drugs
rheumatoid arthritis
respiratory syndrome coronavirus
oxidative stress
stem cells
juvenile idiopathic arthritis
mesenchymal stem cells
systemic lupus erythematosus
trauma patients